Xian Qiu
Xian Qiu
Department of Nuclear Medicine, Shanghai Jiao Tong University Affiliated Sixth People’s Hospital, Shanghai, China
Search for other papers by Xian Qiu in
Google Scholar
PubMed
Search for other papers by Xian Qiu in
Google Scholar
PubMed
Lin Cheng
Lin Cheng
Department of Nuclear Medicine, Shanghai Jiao Tong University Affiliated Sixth People’s Hospital, Shanghai, China
Search for other papers by Lin Cheng in
Google Scholar
PubMed
Search for other papers by Lin Cheng in
Google Scholar
PubMed
Ri Sa
Ri Sa
Department of Nuclear Medicine, Shanghai Jiao Tong University Affiliated Sixth People’s Hospital, Shanghai, China
Department of Nuclear Medicine, The First Hospital of Jilin University, Changchun, China
Search for other papers by Ri Sa in
Google Scholar
PubMed
Department of Nuclear Medicine, The First Hospital of Jilin University, Changchun, China
Search for other papers by Ri Sa in
Google Scholar
PubMed
Hao Fu
Hao Fu
Department of Nuclear Medicine, Shanghai Jiao Tong University Affiliated Sixth People’s Hospital, Shanghai, China
Department of Nuclear Medicine & Minnan PET Center, The First Affiliated Hospital of Xiamen University, Xiamen, China
Search for other papers by Hao Fu in
Google Scholar
PubMed
Department of Nuclear Medicine & Minnan PET Center, The First Affiliated Hospital of Xiamen University, Xiamen, China
Search for other papers by Hao Fu in
Google Scholar
PubMed
Yuchen Jin
Yuchen Jin
Department of Nuclear Medicine, Shanghai Jiao Tong University Affiliated Sixth People’s Hospital, Shanghai, China
Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, New York, USA
Search for other papers by Yuchen Jin in
Google Scholar
PubMed
Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, New York, USA
Search for other papers by Yuchen Jin in
Google Scholar
PubMed
Libo Chen
Libo Chen
Department of Nuclear Medicine, Shanghai Jiao Tong University Affiliated Sixth People’s Hospital, Shanghai, China
Search for other papers by Libo Chen in
Google Scholar
PubMed
Search for other papers by Libo Chen in
Google Scholar
PubMed
commonly achieved because of its indolent nature and adequate management strategies, including surgery, radioiodine ( 131 I) treatment, and levothyroxine therapy ( 2 ). However, persistent/recurrent or metastatic DTC, which is refractory to 131 I therapy
Abdul Rehman Syed
Abdul Rehman Syed
University of Calgary, Calgary, Alberta, Canada
Search for other papers by Abdul Rehman Syed in
Google Scholar
PubMed
Search for other papers by Abdul Rehman Syed in
Google Scholar
PubMed
Aakash Gorana
Aakash Gorana
Arnie Charbonneau Cancer Institute, Cumming School of Medicine, University of Calgary, Alberta, Canada
Search for other papers by Aakash Gorana in
Google Scholar
PubMed
Search for other papers by Aakash Gorana in
Google Scholar
PubMed
Erik Nohr
Erik Nohr
Alberta Precision Laboratories, Molecular Pathology Program, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada
Search for other papers by Erik Nohr in
Google Scholar
PubMed
Search for other papers by Erik Nohr in
Google Scholar
PubMed
Xiaoli-Kat Yuan
Xiaoli-Kat Yuan
Precision Oncology Hub Laboratory, Tom Baker Cancer Centre, Calgary, Alberta, Canada
Search for other papers by Xiaoli-Kat Yuan in
Google Scholar
PubMed
Search for other papers by Xiaoli-Kat Yuan in
Google Scholar
PubMed
Parthiv Amin MASc
Parthiv Amin MASc
Department of Radiology, Cumming School of Medicine, University of Calgary, Calgary Alberta, Canada
Search for other papers by Parthiv Amin MASc in
Google Scholar
PubMed
Search for other papers by Parthiv Amin MASc in
Google Scholar
PubMed
Sana Ghaznavi
Sana Ghaznavi
Arnie Charbonneau Cancer Institute, Department of Medicine, Section of Endocrinology, University of Calgary, Calgary, Alberta, Canada
Search for other papers by Sana Ghaznavi in
Google Scholar
PubMed
Search for other papers by Sana Ghaznavi in
Google Scholar
PubMed
Debbie Lamb
Debbie Lamb
Arnie Charbonneau Cancer Institute, Cumming School of Medicine, University of Calgary, Alberta, Canada
Search for other papers by Debbie Lamb in
Google Scholar
PubMed
Search for other papers by Debbie Lamb in
Google Scholar
PubMed
John McIntyre
John McIntyre
Precision Oncology Hub Laboratory, Tom Baker Cancer Centre, Calgary, Alberta, Canada
Search for other papers by John McIntyre in
Google Scholar
PubMed
Search for other papers by John McIntyre in
Google Scholar
PubMed
Markus Eszlinger
Markus Eszlinger
Department of Oncology, Cumming School of Medicine, and Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, Alberta, Canada
Search for other papers by Markus Eszlinger in
Google Scholar
PubMed
Search for other papers by Markus Eszlinger in
Google Scholar
PubMed
Ralf Paschke
Ralf Paschke
Departments of Medicine, Section of Endocrinology, Oncology, Pathology and Laboratory Medicine, Biochemistry and Molecular Biology and Arnie Charbonneau Cancer Institute, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada
Search for other papers by Ralf Paschke in
Google Scholar
PubMed
Search for other papers by Ralf Paschke in
Google Scholar
PubMed
treatment ( 1 ). Two-thirds of metastatic DTCs lose their ability to uptake radioiodine (RAI) due to oncogene driver mutations silencing thyroid iodide-metabolizing genes, causing them to be RAI-resistant or refractory ( 1 , 2 , 3 ). Patients with RAI
E.N. Klein Hesselink
E.N. Klein Hesselink
Department of Endocrinology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands
Search for other papers by E.N. Klein Hesselink in
Google Scholar
PubMed
Search for other papers by E.N. Klein Hesselink in
Google Scholar
PubMed
T.P. Links
T.P. Links
Department of Endocrinology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands
Search for other papers by T.P. Links in
Google Scholar
PubMed
Search for other papers by T.P. Links in
Google Scholar
PubMed
, standardized treatment has consisted of a total thyroidectomy accompanied by a central or lateral neck lymph node dissection if indicated, followed by radioiodine ( 131 I) ablation, and thyroid hormone suppression therapy (THST) during follow-up. Although
Aamna Hassan
Aamna Hassan
Departments of Nuclear Medicine, Shaukat Khanum Memorial Cancer Hospital and Research Centre, Lahore, Pakistan
Search for other papers by Aamna Hassan in
Google Scholar
PubMed
Search for other papers by Aamna Hassan in
Google Scholar
PubMed
Saima Riaz
Saima Riaz
Departments of Nuclear Medicine, Shaukat Khanum Memorial Cancer Hospital and Research Centre, Lahore, Pakistan
Search for other papers by Saima Riaz in
Google Scholar
PubMed
Search for other papers by Saima Riaz in
Google Scholar
PubMed
Humayun Bashir
Humayun Bashir
Departments of Nuclear Medicine, Shaukat Khanum Memorial Cancer Hospital and Research Centre, Lahore, Pakistan
Search for other papers by Humayun Bashir in
Google Scholar
PubMed
Search for other papers by Humayun Bashir in
Google Scholar
PubMed
M. Khalid Nawaz
M. Khalid Nawaz
Departments of Nuclear Medicine, Shaukat Khanum Memorial Cancer Hospital and Research Centre, Lahore, Pakistan
Search for other papers by M. Khalid Nawaz in
Google Scholar
PubMed
Search for other papers by M. Khalid Nawaz in
Google Scholar
PubMed
Raza Hussain
Raza Hussain
Departments of Surgical Oncology, Shaukat Khanum Memorial Cancer Hospital and Research Centre, Lahore, Pakistan
Search for other papers by Raza Hussain in
Google Scholar
PubMed
Search for other papers by Raza Hussain in
Google Scholar
PubMed
Introduction Differentiated thyroid cancer (DTC) is typically indolent if treated early and appropriately. A small subset of more aggressive disease progresses to radioiodine resistance. Based on the American Thyroid Association (ATA) risk of
Yasmine Abdellaoui
Yasmine Abdellaoui
Department of Internal Medicine, Foch Hospital, Suresnes, France
Search for other papers by Yasmine Abdellaoui in
Google Scholar
PubMed
Search for other papers by Yasmine Abdellaoui in
Google Scholar
PubMed
Dimitra Magkou
Dimitra Magkou
Department of Endocrinology and Nutrition, Ambroise Paré Universitary Hospital, Assistance Publique Hôpitaux de Paris, Boulogne, France
Search for other papers by Dimitra Magkou in
Google Scholar
PubMed
Search for other papers by Dimitra Magkou in
Google Scholar
PubMed
Sofia Bakopoulou
Sofia Bakopoulou
Department of Endocrinology and Nutrition, Ambroise Paré Universitary Hospital, Assistance Publique Hôpitaux de Paris, Boulogne, France
Search for other papers by Sofia Bakopoulou in
Google Scholar
PubMed
Search for other papers by Sofia Bakopoulou in
Google Scholar
PubMed
Ramona Zaharia
Ramona Zaharia
Department of Endocrinology and Nutrition, Ambroise Paré Universitary Hospital, Assistance Publique Hôpitaux de Paris, Boulogne, France
Search for other papers by Ramona Zaharia in
Google Scholar
PubMed
Search for other papers by Ramona Zaharia in
Google Scholar
PubMed
Marie-Laure Raffin-Sanson
Marie-Laure Raffin-Sanson
Department of Endocrinology and Nutrition, Ambroise Paré Universitary Hospital, Assistance Publique Hôpitaux de Paris, Boulogne, France
EA 4340, Université Versailles Saint Quentin en Yvelines, UFR Simone Veil Santé, Montigny le Bretonneux, France
Search for other papers by Marie-Laure Raffin-Sanson in
Google Scholar
PubMed
EA 4340, Université Versailles Saint Quentin en Yvelines, UFR Simone Veil Santé, Montigny le Bretonneux, France
Search for other papers by Marie-Laure Raffin-Sanson in
Google Scholar
PubMed
Laure Cazabat
Laure Cazabat
Department of Endocrinology and Nutrition, Ambroise Paré Universitary Hospital, Assistance Publique Hôpitaux de Paris, Boulogne, France
EA 4340, Université Versailles Saint Quentin en Yvelines, UFR Simone Veil Santé, Montigny le Bretonneux, France
Search for other papers by Laure Cazabat in
Google Scholar
PubMed
EA 4340, Université Versailles Saint Quentin en Yvelines, UFR Simone Veil Santé, Montigny le Bretonneux, France
Search for other papers by Laure Cazabat in
Google Scholar
PubMed
What Is Known about This Topic? Both Graves’ disease and autoimmune hypothyroidism were described in patients with resistance to thyroid hormone beta (RTHβ). Undiagnosed RTHβ can lead to misdiagnosis of Graves’ disease. The
Lucie Allard
Lucie Allard
Sorbonne Université, GRC n°16, GRC Tumeurs Thyroïdiennes, Unité Thyroïde-Tumeurs Endocrines, AP-HP, Hôpital Pitié-Salpêtrière, Paris, France
Search for other papers by Lucie Allard in
Google Scholar
PubMed
Search for other papers by Lucie Allard in
Google Scholar
PubMed
Jérôme Alexandre Denis
Jérôme Alexandre Denis
Sorbonne Université, GRC n°16, GRC Tumeurs Thyroïdiennes, Service de Biochimie Endocrinienne et Oncologique, UF Oncobiologie Cellulaire et Moléculaire, Pitié Salpêtrière, AP-HP, Hôpital Pitié-Salpêtrière, Paris, France
Search for other papers by Jérôme Alexandre Denis in
Google Scholar
PubMed
Search for other papers by Jérôme Alexandre Denis in
Google Scholar
PubMed
Gaëlle Godiris Petit
Gaëlle Godiris Petit
Sorbonne Université, GRC n°16, GRC Tumeurs Thyroïdiennes, Service de Chirurgie Générale, Viscérale et Endocrinienne, AP-HP, Hôpital Pitié-Salpêtrière, Paris, France
Search for other papers by Gaëlle Godiris Petit in
Google Scholar
PubMed
Search for other papers by Gaëlle Godiris Petit in
Google Scholar
PubMed
Gabrielle Deniziaut
Gabrielle Deniziaut
Sorbonne Université, GRC n°16, GRC Tumeurs Thyroïdiennes, Service d’Anatomo-Pathologie, AP-HP, Hôpital Pitié-Salpêtrière, Paris, France
Search for other papers by Gabrielle Deniziaut in
Google Scholar
PubMed
Search for other papers by Gabrielle Deniziaut in
Google Scholar
PubMed
Cécile Ghander
Cécile Ghander
Sorbonne Université, GRC n°16, GRC Tumeurs Thyroïdiennes, Unité Thyroïde-Tumeurs Endocrines, AP-HP, Hôpital Pitié-Salpêtrière, Paris, France
Search for other papers by Cécile Ghander in
Google Scholar
PubMed
Search for other papers by Cécile Ghander in
Google Scholar
PubMed
Elise Mathy
Elise Mathy
Sorbonne Université, GRC n°16, GRC Tumeurs Thyroïdiennes, Unité Thyroïde-Tumeurs Endocrines, AP-HP, Hôpital Pitié-Salpêtrière, Paris, France
Search for other papers by Elise Mathy in
Google Scholar
PubMed
Search for other papers by Elise Mathy in
Google Scholar
PubMed
Erell Guillerm
Erell Guillerm
Sorbonne Université, GRC n°16, GRC Tumeurs Thyroïdiennes, UF d’Onco-Angiogénétique et Génomique des Tumeurs Solides, AP-HP, Hôpital Pitié-Salpêtrière, Paris, France
Search for other papers by Erell Guillerm in
Google Scholar
PubMed
Search for other papers by Erell Guillerm in
Google Scholar
PubMed
Charlotte Lussey-Lepoutre
Charlotte Lussey-Lepoutre
Sorbonne Université, GRC n°16, GRC Tumeurs Thyroïdiennes, Service de Médecine Nucléaire, AP-HP, Hôpital Pitié-Salpêtrière, Paris, France
Search for other papers by Charlotte Lussey-Lepoutre in
Google Scholar
PubMed
Search for other papers by Charlotte Lussey-Lepoutre in
Google Scholar
PubMed
Laurence Leenhardt
Laurence Leenhardt
Sorbonne Université, GRC n°16, GRC Tumeurs Thyroïdiennes, Unité Thyroïde-Tumeurs Endocrines, AP-HP, Hôpital Pitié-Salpêtrière, Paris, France
Search for other papers by Laurence Leenhardt in
Google Scholar
PubMed
Search for other papers by Laurence Leenhardt in
Google Scholar
PubMed
Camille Buffet
Camille Buffet
Sorbonne Université, GRC n°16, GRC Tumeurs Thyroïdiennes, Unité Thyroïde-Tumeurs Endocrines, AP-HP, Hôpital Pitié-Salpêtrière, Paris, France
Search for other papers by Camille Buffet in
Google Scholar
PubMed
Search for other papers by Camille Buffet in
Google Scholar
PubMed
known for being predictive of radioiodine resistance ( 1 ). Considering both mutations and the patient’s advanced age and low autonomy, the multidisciplinary panel agreed to avoid iodine treatment. Post-operative 3-month evaluation showed an empty
Nandhini Lakshmana Perumal
Nandhini Lakshmana Perumal
Department of Endocrinology and Metabolism, Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), Puducherry, India
Search for other papers by Nandhini Lakshmana Perumal in
Google Scholar
PubMed
Search for other papers by Nandhini Lakshmana Perumal in
Google Scholar
PubMed
Jayakumar Selvi
Jayakumar Selvi
Department of Endocrinology and Metabolism, Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), Puducherry, India
Search for other papers by Jayakumar Selvi in
Google Scholar
PubMed
Search for other papers by Jayakumar Selvi in
Google Scholar
PubMed
Kalyani Sridharan
Kalyani Sridharan
Department of Endocrinology and Metabolism, Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), Puducherry, India
Search for other papers by Kalyani Sridharan in
Google Scholar
PubMed
Search for other papers by Kalyani Sridharan in
Google Scholar
PubMed
Jayaprakash Sahoo
Jayaprakash Sahoo
Department of Endocrinology and Metabolism, Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), Puducherry, India
Search for other papers by Jayaprakash Sahoo in
Google Scholar
PubMed
Search for other papers by Jayaprakash Sahoo in
Google Scholar
PubMed
Sadishkumar Kamalanathan
Sadishkumar Kamalanathan
Department of Endocrinology and Metabolism, Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), Puducherry, India
Search for other papers by Sadishkumar Kamalanathan in
Google Scholar
PubMed
Search for other papers by Sadishkumar Kamalanathan in
Google Scholar
PubMed
abnormal glucose tolerance and diabetes mellitus have been reported to occur in a significant proportion of patients with hyperthyroidism [ 2 ]. Several factors like changes in insulin resistance, beta-cell function, abnormal gastric emptying, and
Pepijn van Houten
Pepijn van Houten
Department of Internal Medicine, Division of Endocrinology, Radboud University Medical Center, Nijmegen, the Netherlands
Search for other papers by Pepijn van Houten in
Google Scholar
PubMed
Search for other papers by Pepijn van Houten in
Google Scholar
PubMed
James Nagarajah
James Nagarajah
Roentgeninstitut Duesseldorf, Duesseldorf, Germany
Department of Radiology and Nuclear Medicine, Radboud University Medical Center, Nijmegen, the Netherlands
Search for other papers by James Nagarajah in
Google Scholar
PubMed
Department of Radiology and Nuclear Medicine, Radboud University Medical Center, Nijmegen, the Netherlands
Search for other papers by James Nagarajah in
Google Scholar
PubMed
Janneke E W Walraven
Janneke E W Walraven
Department of Medical Oncology, Radboud University Medical Center, Nijmegen, the Netherlands
Search for other papers by Janneke E W Walraven in
Google Scholar
PubMed
Search for other papers by Janneke E W Walraven in
Google Scholar
PubMed
Martin Jaeger
Martin Jaeger
Department of Internal Medicine, Division of Endocrinology, Radboud University Medical Center, Nijmegen, the Netherlands
Search for other papers by Martin Jaeger in
Google Scholar
PubMed
Search for other papers by Martin Jaeger in
Google Scholar
PubMed
Adriana C H van Engen-van Grunsven
Adriana C H van Engen-van Grunsven
Department of Pathology, Radboud University Medical Center, Nijmegen, the Netherlands
Search for other papers by Adriana C H van Engen-van Grunsven in
Google Scholar
PubMed
Search for other papers by Adriana C H van Engen-van Grunsven in
Google Scholar
PubMed
Johannes W Smit
Johannes W Smit
Department of Internal Medicine, Division of Endocrinology, Radboud University Medical Center, Nijmegen, the Netherlands
Search for other papers by Johannes W Smit in
Google Scholar
PubMed
Search for other papers by Johannes W Smit in
Google Scholar
PubMed
Romana T Netea-Maier
Romana T Netea-Maier
Department of Internal Medicine, Division of Endocrinology, Radboud University Medical Center, Nijmegen, the Netherlands
Research Center for Functional Genomics, Biomedicine and Translational Medicine, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania
Search for other papers by Romana T Netea-Maier in
Google Scholar
PubMed
Research Center for Functional Genomics, Biomedicine and Translational Medicine, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania
Search for other papers by Romana T Netea-Maier in
Google Scholar
PubMed
-enable treatment with RAI for tumors previously deemed RAI refractory, potentially providing patients with new treatment options ( 5 ). RAI resistance can be the consequence of the so-called NMTC ‘dedifferentiation’, which is a process in which the accumulation
Luca Persani
Luca Persani
Department of Endocrine and Metabolic Diseases, IRCCS Istituto Auxologico Italiano, Milano, Italy
Department of Medical Biotechnology and Translational Medicine, University of Milan, Milano, Italy
Search for other papers by Luca Persani in
Google Scholar
PubMed
Department of Medical Biotechnology and Translational Medicine, University of Milan, Milano, Italy
Search for other papers by Luca Persani in
Google Scholar
PubMed
Patrice Rodien
Patrice Rodien
Service d’Endocrinologie-Diabétologie-Nutrition, Centre de référence des maladies rares de la Thyroïde et des récepteurs hormonaux, CHU d’Angers, Angers, France.
Search for other papers by Patrice Rodien in
Google Scholar
PubMed
Search for other papers by Patrice Rodien in
Google Scholar
PubMed
Carla Moran
Carla Moran
Institute of Metabolic Science, University of Cambridge, Cambridge, UK
Endocrine Section, Beacon Hospital, Dublin, Ireland.
School of Medicine, University College Dublin, Ireland
Endocrinology Department, St Vincent’s University Hospital, Dublin, Ireland
Search for other papers by Carla Moran in
Google Scholar
PubMed
Endocrine Section, Beacon Hospital, Dublin, Ireland.
School of Medicine, University College Dublin, Ireland
Endocrinology Department, St Vincent’s University Hospital, Dublin, Ireland
Search for other papers by Carla Moran in
Google Scholar
PubMed
W Edward Visser
W Edward Visser
Department of Internal Medicine and Rotterdam Thyroid Center, Erasmus University Medical Center, Rotterdam, The Netherlands
Search for other papers by W Edward Visser in
Google Scholar
PubMed
Search for other papers by W Edward Visser in
Google Scholar
PubMed
Stefan Groeneweg
Stefan Groeneweg
Department of Internal Medicine and Rotterdam Thyroid Center, Erasmus University Medical Center, Rotterdam, The Netherlands
Search for other papers by Stefan Groeneweg in
Google Scholar
PubMed
Search for other papers by Stefan Groeneweg in
Google Scholar
PubMed
Robin Peeters
Robin Peeters
Department of Internal Medicine and Rotterdam Thyroid Center, Erasmus University Medical Center, Rotterdam, The Netherlands
Search for other papers by Robin Peeters in
Google Scholar
PubMed
Search for other papers by Robin Peeters in
Google Scholar
PubMed
Samuel Refetoff
Samuel Refetoff
Departments of Medicine and Paediatrics and Committee on Genetics, The University of Chicago, Chicago, Illinois, USA
Search for other papers by Samuel Refetoff in
Google Scholar
PubMed
Search for other papers by Samuel Refetoff in
Google Scholar
PubMed
Mark Gurnell
Mark Gurnell
Institute of Metabolic Science, University of Cambridge, Cambridge, UK
Search for other papers by Mark Gurnell in
Google Scholar
PubMed
Search for other papers by Mark Gurnell in
Google Scholar
PubMed
Paolo Beck-Peccoz
Paolo Beck-Peccoz
Department of Medical Biotechnology and Translational Medicine, University of Milan, Milano, Italy
Search for other papers by Paolo Beck-Peccoz in
Google Scholar
PubMed
Search for other papers by Paolo Beck-Peccoz in
Google Scholar
PubMed
Krishna Chatterjee
Krishna Chatterjee
Institute of Metabolic Science, University of Cambridge, Cambridge, UK
Search for other papers by Krishna Chatterjee in
Google Scholar
PubMed
Search for other papers by Krishna Chatterjee in
Google Scholar
PubMed
exert their physiological effects principally by regulating the expression of target genes via hormone-inducible nuclear receptors (TRα and TRβ). A consensus statement after the 12th International Workshop on resistance to thyroid hormone widened the
Simone De Leo
Simone De Leo
Division of Endocrine and Metabolic Diseases, IRCCS Istituto Auxologico Italiano, Milan, Italy
Search for other papers by Simone De Leo in
Google Scholar
PubMed
Search for other papers by Simone De Leo in
Google Scholar
PubMed
Carla Colombo
Carla Colombo
Division of Endocrine and Metabolic Diseases, IRCCS Istituto Auxologico Italiano, Milan, Italy
Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Milan, Italy
Search for other papers by Carla Colombo in
Google Scholar
PubMed
Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Milan, Italy
Search for other papers by Carla Colombo in
Google Scholar
PubMed
Marta Di Stefano
Marta Di Stefano
Department of Clinical Sciences and Community Health, Università degli Studi di Milano, Milan, Italy
Search for other papers by Marta Di Stefano in
Google Scholar
PubMed
Search for other papers by Marta Di Stefano in
Google Scholar
PubMed
Antonella Dubini
Antonella Dubini
Division of Laboratory Medicine, IRCCS Istituto Auxologico Italiano, Milan, Italy
Search for other papers by Antonella Dubini in
Google Scholar
PubMed
Search for other papers by Antonella Dubini in
Google Scholar
PubMed
Silvia Cozzi
Silvia Cozzi
Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Milan, Italy
Search for other papers by Silvia Cozzi in
Google Scholar
PubMed
Search for other papers by Silvia Cozzi in
Google Scholar
PubMed
Luca Persani
Luca Persani
Division of Endocrine and Metabolic Diseases, IRCCS Istituto Auxologico Italiano, Milan, Italy
Department of Clinical Sciences and Community Health, Università degli Studi di Milano, Milan, Italy
Search for other papers by Luca Persani in
Google Scholar
PubMed
Department of Clinical Sciences and Community Health, Università degli Studi di Milano, Milan, Italy
Search for other papers by Luca Persani in
Google Scholar
PubMed
Laura Fugazzola
Laura Fugazzola
Division of Endocrine and Metabolic Diseases, IRCCS Istituto Auxologico Italiano, Milan, Italy
Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Milan, Italy
Search for other papers by Laura Fugazzola in
Google Scholar
PubMed
Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Milan, Italy
Search for other papers by Laura Fugazzola in
Google Scholar
PubMed
, which is a potent inhibitor of vascular endothelial growth factor receptors, currently used for advanced, radioiodine refractory differentiated TC [ 4 ]. In the registration study, as in the “real life” following reports, weight loss occurred in 46
